Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Healtang Biotech Co., Ltd. is a prominent biotechnology firm based in China, specializing in the production of functional sugar alcohols and healthy sweeteners. As a core subsidiary of the Futaste Group, the company leverages advanced fermentation and enzymatic processes to manufacture high-purity xylitol, erythritol, L-arabinose, and maltitol. These products are widely utilized as pharmaceutical excipients and food additives, targeting the global health and wellness markets, particularly for diabetes management and oral care. Healtang Biotech operates large-scale manufacturing facilities with international certifications including GMP, ISO, and HACCP. The company is recognized as a National High-tech Enterprise and maintains a strong focus on R&D in bio-based materials and functional ingredients. Its products are exported to over 50 countries, supporting the evolving needs of the life sciences and food industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healtang Biotech.